People

Jeroen Roose, PI

I am a cellular systems biologist with a long-standing focus on oncogenic signaling, cell fitness, and cell fate decisions in cancer, stem cell biology, and immunology. I received my PhD training in The Netherlands in the laboratory of Dr. Hans Clevers, studying Wnt signaling and cancer, followed by postdoctoral training at UCSF with Dr. Arthur Weiss investigating Ras signaling in lymphocytes. These experiences shaped my long-standing interest in cellular fitness across tissues and disease, and I established my independent laboratory at UCSF in 2007, where I currently serve as Professor and Vice Chair of Anatomy. 

[email protected]

Connect with Dr. Roose on Linkedin

Other Roose Lab websites:

Roose Lab in the Anatomy Department

Roose Lab in the UCSF BMS Program

Roose Lab in ImmunoX

Roose Lab in the UCSF Helen Diller Family Comprehensive Cancer Center

Jeroen Roose in UCSF Profiles

 

Administrative Support


 

Kayla Acuna

[email protected]

Administrative Assistant
Administrative support for Jeroen Roose

 


Staff

Michelle (Oghenekvwe) Gbenedio

[email protected]

I lead the Roose Organoid Core, where I develop and apply patient-derived organoid technologies to enable collaborative research across multiple disease areas. In addition to supporting investigators in experimental design and organoid model development, I lead an independent research project investigating Ras signaling and tumor evolution in pancreatic ductal adenocarcinoma (PDAC).


Graduate students

 

Lauren Shechtman

[email protected]

xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

 

Khang Nguyen

[email protected]

Although immune checkpoint inhibitors (ICIs) have improved outcomes in non-small cell lung cancer (NSCLC), their efficacy is limited by T cell exhaustion. I am developing autologous T cell–tumor assembloids by co-culturing patient-derived organoids with matched peripheral blood T cells. Integrated single-cell transcriptomics, TCR sequencing, and functional analyses identify clinically relevant programs of T cell exhaustion, antitumor immunity, and therapeutic TCRs.

 

Esther Sim

[email protected]

 

xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

 

 

Marcela García Jiménez

[email protected]

xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

 


Postdoctoral Fellows

Rachel Waldemer-Streyer, MD.

[email protected]

xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

 

 

Mario Ruiz Perez

[email protected]

xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

 

 

Jesse Garcia Castillo

[email protected]

xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

 


Lab Support

Nicole Yee

[email protected]

Post-award financial analyst

 

 

Elena Pozdniakova

[email protected]

Pre-award grant specialist

 

 

Lelaine Pata

Supporting Service